Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies
The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the “pharmacy of the world,” it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&D, cost-effective manufacturing, and a skilled workforce.
Companies like Sun Pharma, Dr. Reddy’s, Cipla, and Lupin lead the sector. With increasing healthcare spending, rising chronic diseases, and export demand, India’s pharma industry has immense growth potential, especially in biotechnology, biosimilars, and innovative drug development.
India: The CDMO Capital of the World
India is known as the “CDMO (Contract Development and Manufacturing Organization) capital of the world,” dominating the global pharmaceutical outsourcing market. Indian companies provide end-to-end solutions, including drug development, manufacturing, and packaging, to major global pharma players.